CDKN2A and plasma cell myeloma: Another integrative bioinformatics analysis revealed that CDKN2A shows a significant correlation with immune signatures in multiple myeloma, including CD4+ regulatory T cells, T cell exhaustion, and neutrophils (Tuerxun et al., 2022).